A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase

被引:62
作者
Levy, CW
Baldock, C
Wallace, AJ
Sedelnikova, S
Viner, RC
Clough, JM
Stuitje, AR
Slabas, AR
Rice, DW
Rafferty, JB [1 ]
机构
[1] Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
[2] Zeneca Agrochem, Jealotts Hill Res Stn, Bracknell RG42 6ET, Berks, England
[3] Vrije Univ Amsterdam, Dept Genet, NL-1081 HV Amsterdam, Netherlands
[4] Univ Durham, Dept Biol Sci, Durham DH1 3LE, England
基金
英国生物技术与生命科学研究理事会;
关键词
diazaborine; inhibitor binding; enoyl reductase; crystal structure; antibacterial activity;
D O I
10.1006/jmbi.2001.4643
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enoyl acyl carrier protein (ACP) reductase catalyses the last reductive step of fatty acid biosynthesis, reducing the enoyl group of a growing fatty acid chain attached to ACP to its acyl product using NAD(P)H as the cofactor. This enzyme is the target for the diazaborine class of anti bacterial agents, the biocide triclosan, and one of the targets for the frontline anti-tuberculosis drug isoniazid. The structures of complexes of Escherichia coli enoyl-ACP reductase (ENR) from crystals grown in the presence of NAD(+) and a family of diazaborine compounds have been determined. Analysis of the structures has revealed that a mobile loop in the structure of the binary complex with NAD+ becomes ordered on binding diazaborine/NAD(+) but displays a different conformation in the two subunits of the asymmetric unit. The work presented here reveals how, for one of the ordered conformations adopted by the mobile loop, the mode of diazaborine binding correlates well with the activity profiles of the diazaborine family. Additionally, diazaborine binding provides insights into the pocket on the enzyme surface occupied by the growing fatty acid chain. (C) 2001 Academic Press.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 22 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Crystallization of Escherichia coli enoyl reductase and its complex with diazaborine [J].
Baldock, C ;
Rafferty, JB ;
Sedelnikova, SE ;
Bithell, S ;
Stuitje, AR ;
Slabas, AR ;
Rice, DW .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :1181-1184
[3]   A mechanism of drug action revealed by structural studies of enoyl reductase [J].
Baldock, C ;
Rafferty, JB ;
Sedelnikova, SE ;
Baker, PJ ;
Stuitje, AR ;
Slabas, AR ;
Hawkes, TR ;
Rice, DW .
SCIENCE, 1996, 274 (5295) :2107-2110
[4]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[5]  
BERGLER H, 1994, J BIOL CHEM, V269, P5493
[6]   CRYSTAL-STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM-TUBERCULOSIS [J].
DESSEN, A ;
QUEMARD, A ;
BLANCHARD, JS ;
JACOBS, WR ;
SACCHETTINI, JC .
SCIENCE, 1995, 267 (5204) :1638-1641
[7]   PREPARATION AND ANTIBACTERIAL ACTIVITIES OF NEW 1,2,3-DIAZABORINE DERIVATIVES AND ANALOGS [J].
GRASSBERGER, MA ;
TURNOWSKY, F ;
HILDEBRANDT, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (08) :947-953
[8]   A DIAZABORINE DERIVATIVE INHIBITS LIPOPOLYSACCHARIDE BIOSYNTHESIS [J].
HOGENAUER, G ;
WOISETSCHLAGER, M .
NATURE, 1981, 293 (5834) :662-664
[9]   GRAPHICS MODEL-BUILDING AND REFINEMENT SYSTEM FOR MACROMOLECULES [J].
JONES, TA .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1978, 11 (AUG) :268-272
[10]   SOLUTION FOR BEST ROTATION TO RELATE 2 SETS OF VECTORS [J].
KABSCH, W .
ACTA CRYSTALLOGRAPHICA SECTION A, 1976, 32 (SEP1) :922-923